Grifols, S.A.

Healthcare

NASDAQ:GRFS · NASDAQ Global Select

Market Cap $6.29B Beta 1.17 P/E (TTM) 14.7

$7.40 +0.34%

+$0.03 today

52W Low $7.26High $11.14

Vol 0.96M · Avg 0.69M

EPS (TTM) $0.61 Div Yield 1.67%Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-10.41%

Period High

$10.74

Period Low

$7.32

Latest

$7.40

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.53B

Molina Healthcare, Inc.

NYSE:MOH

$10.33B

Globus Medical, Inc.

NYSE:GMED

$10.24B

Masimo Corporation

NASDAQ:MASI

$9.42B

Henry Schein, Inc.

NASDAQ:HSIC

$9.07B

Corcept Therapeutics Incorporated

NASDAQ:CORT

$8.84B

Halozyme Therapeutics, Inc.

NASDAQ:HALO

$8.10B

AptarGroup, Inc.

NYSE:ATR

$7.76B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.66B

Avantor, Inc.

NYSE:AVTR

$6.50B

What is the latest GRFS filing?

The latest filing shown is 6-K dated May 15, 2026.

How many recent filings does GRFS have?

Intrinsic Alpha currently shows 20 recent filings for GRFS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.